BioSpace News Archive

Since 2014, Leading Duchenne Organization Has Certified Outstanding Clinics that Provide Optimal Care for People with Duchenne Muscular Dystrophy

The market will accelerate at a CAGR of nearly 12% between 2019-2023

PercayAI, a newly launched augmented intelligence software company that helps researchers develop new drugs more quickly and successfully, is announcing its first strategic, commercial partnership with Canopy Biosciences®.

Virtual Health Partners, Inc. (VHP), a virtual health and wellness company, today announced a partnership with HealthyResponders.com, operated by The Holdsworth Group, an international consulting firm that provides marketing, strategic planning and executive coaching services to clients in the EMS, healthcare, and government industries.

Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical therapies to address unmet needs in dermatology, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for FMX103 (minocycline topical foam 1.5%) topical foam.

CUBEX LLC, a leading provider of medication and supply management technology, announced the launch of its new venture, ZIMBIS, a division focused solely on solving the inventory management challenges of the dental market.

Clarify Medical will present adherence and satisfaction data from 30 patients using the connected Clarify Home Light Therapy System during a clinical poster session at The Fall Clinical Dermatology Conference in Las Vegas.

National Technical Systems, Inc. (“NTS”), the leader in qualification testing, inspection, and certification solutions in North America, hosted the Institute of Electrical and Electronics Engineers (IEEE) EMI/EMC Summit at its laboratory in Boxborough, Massachusetts

Lysogene (Paris:LYS) (FR0013233475 – LYS), a pioneering Phase 3 biopharmaceutical company specializing in gene therapy targeting central nervous system (CNS) diseases, today announced the appointment of Stéphane Durant des Aulnois as Chief Financial Officer

Synaptive Medical, a leader in automation and robotics, announced today a strategic commercial expansion into the spinal surgery market.